Literature DB >> 7236891

A procedure for removing high titer antibodies by extracorporeal protein-A-sepharose adsorption in hemophilia: substitution therapy and surgery in a patient with hemophilia B and antibodies.

I M Nilsson, S Jonsson, S B Sundqvist, A Ahlberg, S E Bergentz.   

Abstract

A 37-yr-old hemophiliac with factor IX antibody in high titer required operation for a pseudotumor growing invasively into the bone in his left elbow. Exchange plasma-pheresis was not feasible, mainly because of possible stimulation of factor IX inhibitor. In addition, the patient had antibodies against tissue antigens. The factor IX antibodies were of IgG type and adsorbable to protein-A-agarose. The antibodies were removed by extracorporeal adsorption of the plasma (separated intermittently in a cell centrifuge) to sterile protein-A-Sepharose in columns, operated by a computer. The treated plasma was retransfused. In this manner, a total of 6000 ml of plasma was depleted of antibodies, and the antibody titer, as well as the total immunoglobulin content, decreased to one-fifth of the original values. The remaining antibodies were neutralized by infusion of factor IX concentrate. Conventional substitution therapy, in combination with immunosuppression, was then possible. The operation was performed without complications. No signs of hemolysis, complement activation, or activation of the coagulation system occurred. In principle, the same form of treatment can be used in patients with other forms of antibodies.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236891

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Elective surgery in a haemophilic patient with high titre inhibitors: use of extracorporeal protein A immunoabsorption.

Authors:  B J Boughton; A Payne; A Serman; G Owen
Journal:  J Clin Pathol       Date:  1990-02       Impact factor: 3.411

Review 2.  Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes.

Authors:  Amy D Shapiro; Ulla Hedner
Journal:  Ther Adv Drug Saf       Date:  2011-10

3.  IgG immunoadsorption in experimental allergic neuritis: effect on antibody levels and clinical course.

Authors:  G K Harvey; K Schindhelm; J D Pollard
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-07       Impact factor: 10.154

Review 4.  Potential for plasma exchange in children.

Authors:  E A Robinson
Journal:  Arch Dis Child       Date:  1982-04       Impact factor: 3.791

5.  Plasmapheresis in pediatric practice.

Authors:  A Nanu; S K Sood
Journal:  Indian J Pediatr       Date:  1983 Mar-Apr       Impact factor: 1.967

Review 6.  Haemophilia.

Authors:  M R Cahill; B T Colvin
Journal:  Postgrad Med J       Date:  1997-04       Impact factor: 2.401

7.  The effect of extracorporeal antibody removal on antibody synthesis and catabolism in immunized rabbits.

Authors:  B Charlton; K Schindhelm
Journal:  Clin Exp Immunol       Date:  1985-06       Impact factor: 4.330

8.  Induction of split tolerance and clinical cure in high-responding hemophiliacs with factor IX antibodies.

Authors:  I M Nilsson; E Berntorp; O Zettervall
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

9.  Clinical Care of Bone Health in Patients on the Immune Tolerance Induction's Protocols With an Immunosuppressive Agent for Inhibitor Eradication in Hemophilia.

Authors:  Zahra Rezaieyazdi; Hassan Mansouritorghabeh
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.